Get the Stockscreener App
164.84
0.81%
1.32
After Hours:
164.84
Overview
News
Price History
Option Chain
Financials
Why ZTS Down?
Discussions
Forecast
Dividend History
Zoetis Inc stock is traded at $164.84, with a volume of 5.30M.
It is up +0.81% in the last 24 hours and down -6.16% over the past month.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
See More
Previous Close:
$163.52
Open:
$163.76
24h Volume:
5.30M
Relative Volume:
2.42
Market Cap:
$74.37B
Revenue:
$9.15B
Net Income/Loss:
$2.43B
P/E Ratio:
33.50
EPS:
4.92
Net Cash Flow:
$2.31B
1W Performance:
-7.49%
1M Performance:
-6.16%
6M Performance:
-1.99%
1Y Performance:
-15.31%
1-Day Range:
$163.53
$166.39
1-Week Range:
$163.37
$179.29
52-Week Range:
$144.80
$200.53
Zoetis Inc Stock (ZTS) Company Profile
Compare ZTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
164.84 | 74.37B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.81B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
22.09 | 25.03B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.52 | 14.94B | 15.05B | -883.30M | 1.89B | -0.74 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-12-24 | Reiterated | Stifel | Buy |
| Dec-19-23 | Resumed | Jefferies | Buy |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-08-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-08-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-21-20 | Initiated | Atlantic Equities | Overweight |
| Aug-14-20 | Upgrade | Edward Jones | Hold → Buy |
| Aug-12-20 | Downgrade | Gabelli & Co | Buy → Hold |
| May-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Sep-09-19 | Initiated | Goldman | Buy |
| Jul-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-11-19 | Initiated | Barclays | Overweight |
| May-23-19 | Initiated | Guggenheim | Buy |
| May-03-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-04-19 | Upgrade | Stifel | Hold → Buy |
| Jan-23-19 | Initiated | UBS | Neutral |
| Oct-15-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-22-18 | Downgrade | Stifel | Buy → Hold |
| Aug-03-18 | Reiterated | Stifel | Buy |
| Apr-19-18 | Reiterated | Citigroup | Buy |
| Mar-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-16-18 | Reiterated | Stifel | Buy |
| Jan-04-18 | Upgrade | Citigroup | Neutral → Buy |
View All
Zoetis Inc Stock (ZTS) Latest News
M&T Bank Corp Sells 36,434 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Here's Why Zoetis (ZTS) Gained But Lagged the Market Today - Yahoo Finance
Zoetis Inc. stock rises Friday, still underperforms market - MarketWatch
Livestock Drug Market to See Stunning Growth with Zoetis, Elanco, Bayer Animal Health - openPR
Zoetis Inc. (NYSE:ZTS) Receives $215.22 Consensus PT from Brokerages - MarketBeat
Zoetis Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Zoetis is Now Oversold (ZTS) - Nasdaq
📈 Is Zoetis a good stock to buy? - substack.com
Earnings growth of 2.9% over 3 years hasn't been enough to translate into positive returns for Zoetis (NYSE:ZTS) shareholders - Simply Wall St
5 Magnificent Dividend Growth Stocks Down 24% to 41% to Buy Before 2025 for a Lifetime of Passive Income - The Motley Fool
Zoetis dips as FDA cites adverse events linked to canine pain therapy Librela - MSN
Zoetis donates $100,000 to support vet mental health - Vet Practice magazine
Elliott Wave Pattern Puts Zoetis Bulls On Alert - EWM Interactive
Zoetis stock dips after FDA notice on Librela (ZTS:NYSE) - Seeking Alpha
Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet? - Yahoo Finance
Zoetis Issues Vaccine Reminder for Pregnant Broodmares in Third Trimester - EQUUS Magazine
Here's Why Zoetis (ZTS) is a Strong Growth Stock - Yahoo Finance
American Trust Sells 4,044 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Wilmington Savings Fund Society FSB Increases Stock Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
World Investment Advisors LLC Has $6.69 Million Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Stake Lessened by Sanctuary Advisors LLC - MarketBeat
Podcast: Harness Culture to Drive Value with Zoetis’ Supply Chain EVP - Gartner
Zoetis Boosts Dividend by 16% for 2025 - TipRanks
Zoetis Boosts Quarterly Dividend by 16% to Record $0.50, Showcases Strong Financial Performance - StockTitan
Stock Yards Bank & Trust Co. Lowers Stake in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Toronto Dominion Bank Increases Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Veterinary Pain Management Market Is Booming Worldwide - openPR
Why Zoetis Inc. (NYSE:ZTS) Looks Like A Quality Company - Yahoo Finance
TCW Group Inc. Has $123.40 Million Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Geode Capital Management LLC Purchases 185,364 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Companion Animal Diagnostics Market 2024 to Witness Huge Growth - openPR
Zoetis CFO Says Resiliency In Animal Health Enables Innovation - Forbes
Zoetis initiated with a Neutral at UBS - Yahoo Finance
Zoetis : Announces Global Launch of Vetscan OptiCell™ at VMX 2025 - Marketscreener.com
Zoetis to Debut AI-Powered Haematology Technology at London Vet Show - The Eastern Progress Online
Zoetis (NYSE:ZTS) Coverage Initiated at UBS Group - MarketBeat
Tylosin Market Expected to Reach US$ 605 million by 2031 | Zoetis, Tairui Pharmaceuticals, Lukang Pharmaceutical. - openPR
Brophy Wealth Management LLC Acquires New Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Holdings Trimmed by M&T Bank Corp - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Sold by Nomura Asset Management Co. Ltd. - MarketBeat
Veterinary Oncology Market Generated Opportunities, Future - openPR
First National Bank of Omaha Boosts Stock Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zacks Investment Management Invests $15.75 Million in Zoetis Inc. (NYSE:ZTS) - MarketBeat
National Bank of Canada FI Raises Stock Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Acquired by iA Global Asset Management Inc. - MarketBeat
Kovitz Investment Group Partners LLC Raises Stake in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Stock: Is ZTS Underperforming the Healthcare Sector? - Nasdaq
Zoetis: Are Competition And Price Increases A Cause For Concern? (NYSE:ZTS) - Seeking Alpha
What is Zacks Research's Estimate for Zoetis Q1 Earnings? - MarketBeat
Zoetis Stock: Is ZTS Underperforming The Healthcare Sector? - Barchart
Pet Diabetes Care Devices Market CAGR of 7.1% Major Trends, Growth, Demand & forecast By 2024-2031 | Virbac, - EIN News
Zoetis Inc Stock (ZTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.10%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):